Selected article for: "ALA group placebo group and placebo group"

Author: Ming Zhong; Aijun Sun; Ting Xiao; Ge Yao; Ling Sang; Xia Zheng; Jinyan Zhang; Xuejuan Jin; Lei Xu; Wenlong Yang; Peng Wang; Kai Hu; Dingyu Zhang; Junbo Ge
Title: A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of a-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19)
  • Document date: 2020_4_21
  • ID: mvsnybbo_34
    Snippet: The copyright holder for this preprint . https://doi.org/10.1101/2020.04. 15.20066266 doi: medRxiv preprint Figure. 3 Overall Survival; Borderline significance was observed between ALA group and placebo group (P=0.09) at day 30......
    Document: The copyright holder for this preprint . https://doi.org/10.1101/2020.04. 15.20066266 doi: medRxiv preprint Figure. 3 Overall Survival; Borderline significance was observed between ALA group and placebo group (P=0.09) at day 30.

    Search related documents:
    Co phrase search for related documents
    • ALA group and placebo group: 1, 2, 3, 4
    • ALA group and placebo group ALA group: 1, 2, 3
    • Borderline significance and placebo group: 1, 2
    • Borderline significance and placebo group ALA group: 1
    • overall survival and placebo group: 1, 2, 3, 4, 5, 6, 7, 8